Pedi Care Products Industry to 2027

The global pedi care market is growing at steady pace with a growth rate of 6.5-7.0%.

According to this report, the global foot care products market was valued at $2.92 billion in 2019, and is anticipated to reach $4.5 billion by 2027, with a CAGR of 7.10% during the forecast period.

The foot care products market exhibits an incremental revenue opportunity of $1.6 billion from 2020 to 2027.

Rapid growth in e-commerce distribution is the prime factor responsible for counterfeiting of cosmetic products.

According to a report by the Financial Times, the online distribution of non-grocery goods grew by 12.7% to contribute around 24.3% of the total sales in 2018.

The cosmetic industry has been strongly hit by counterfeit activities due to large number of consumers purchasing products through online sales channels.

In addition, lack of brand loyalty among consumers while purchasing cosmetic products is responsible for decrease in penetration of cosmetic products.

Companies operating in the foot care products market face challenges from fake product distributers, thus witnessing decline in terms of sales.

Such increased counterfeit activities due to lack of effective supply chain management is expected to hamper the revenue growth of personal care and cosmetic products market during the forecast period.

The foot care products market is segmented into product, application, distribution channel, and region. By product, it is categorized into foot repair ointment, foot creams, foot cleansing lotions, slough scrub products, and others.

On the basis of application, it is categorized into sports & athletics, medical, and personal comfort. Depending on the distribution channel, it is bifurcated into drug stores & pharmacies, hospitals & clinics, online stores, and others.

Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (GermanyFrance, the UK, Spain, the Italy, and rest of Europe), Asia-Pacific (ChinaJapanIndiaAustraliaSouth Korea, and rest of Asia-Pacific), and LAMEA (Latin AmericaMiddle East, and Africa).

The key players profiled in this report include Johnson & Johnson, Del Laboratories, HoMedics, PediFix, Inc, Alva-Amco Pharmacal, Inc., Revlon, Aetna Foot Products, Blistex Inc., Glaxosmithkline Plc, and Miracle of Aloe.

For more information, visit

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: